Global Hodgkin Lymphoma Treatment Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Alocrest
  • 1.2.3 ANK Program
  • 1.2.4 Azacitidine
  • 1.2.5 BMS-986016
  • 1.2.6 BPX-501
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Research Center
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Hodgkin Lymphoma Treatment Market Perspective (2017-2028)
• 2.2 Hodgkin Lymphoma Treatment Growth Trends by Region
  • 2.2.1 Hodgkin Lymphoma Treatment Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Hodgkin Lymphoma Treatment Historic Market Size by Region (2017-2022)
  • 2.2.3 Hodgkin Lymphoma Treatment Forecasted Market Size by Region (2023-2028)
• 2.3 Hodgkin Lymphoma Treatment Market Dynamics
  • 2.3.1 Hodgkin Lymphoma Treatment Industry Trends
  • 2.3.2 Hodgkin Lymphoma Treatment Market Drivers
  • 2.3.3 Hodgkin Lymphoma Treatment Market Challenges
  • 2.3.4 Hodgkin Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue
  • 3.1.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue (2017-2022)
  • 3.1.2 Global Hodgkin Lymphoma Treatment Revenue Market Share by Players (2017-2022)
• 3.2 Global Hodgkin Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Hodgkin Lymphoma Treatment Revenue
• 3.4 Global Hodgkin Lymphoma Treatment Market Concentration Ratio
  • 3.4.1 Global Hodgkin Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Hodgkin Lymphoma Treatment Revenue in 2021
• 3.5 Hodgkin Lymphoma Treatment Key Players Head office and Area Served
• 3.6 Key Players Hodgkin Lymphoma Treatment Product Solution and Service
• 3.7 Date of Enter into Hodgkin Lymphoma Treatment Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Hodgkin Lymphoma Treatment Breakdown Data by Type

• 4.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Type (2017-2022)
• 4.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2023-2028)

5 Hodgkin Lymphoma Treatment Breakdown Data by Application

• 5.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Application (2017-2022)
• 5.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Hodgkin Lymphoma Treatment Market Size (2017-2028)
• 6.2 North America Hodgkin Lymphoma Treatment Market Size by Type
  • 6.2.1 North America Hodgkin Lymphoma Treatment Market Size by Type (2017-2022)
  • 6.2.2 North America Hodgkin Lymphoma Treatment Market Size by Type (2023-2028)
  • 6.2.3 North America Hodgkin Lymphoma Treatment Market Share by Type (2017-2028)
• 6.3 North America Hodgkin Lymphoma Treatment Market Size by Application
  • 6.3.1 North America Hodgkin Lymphoma Treatment Market Size by Application (2017-2022)
  • 6.3.2 North America Hodgkin Lymphoma Treatment Market Size by Application (2023-2028)
  • 6.3.3 North America Hodgkin Lymphoma Treatment Market Share by Application (2017-2028)
• 6.4 North America Hodgkin Lymphoma Treatment Market Size by Country
  • 6.4.1 North America Hodgkin Lymphoma Treatment Market Size by Country (2017-2022)
  • 6.4.2 North America Hodgkin Lymphoma Treatment Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Hodgkin Lymphoma Treatment Market Size (2017-2028)
• 7.2 Europe Hodgkin Lymphoma Treatment Market Size by Type
  • 7.2.1 Europe Hodgkin Lymphoma Treatment Market Size by Type (2017-2022)
  • 7.2.2 Europe Hodgkin Lymphoma Treatment Market Size by Type (2023-2028)
  • 7.2.3 Europe Hodgkin Lymphoma Treatment Market Share by Type (2017-2028)
• 7.3 Europe Hodgkin Lymphoma Treatment Market Size by Application
  • 7.3.1 Europe Hodgkin Lymphoma Treatment Market Size by Application (2017-2022)
  • 7.3.2 Europe Hodgkin Lymphoma Treatment Market Size by Application (2023-2028)
  • 7.3.3 Europe Hodgkin Lymphoma Treatment Market Share by Application (2017-2028)
• 7.4 Europe Hodgkin Lymphoma Treatment Market Size by Country
  • 7.4.1 Europe Hodgkin Lymphoma Treatment Market Size by Country (2017-2022)
  • 7.4.2 Europe Hodgkin Lymphoma Treatment Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size (2017-2028)
• 8.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type
  • 8.2.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application
  • 8.3.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region
  • 8.4.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Hodgkin Lymphoma Treatment Market Size (2017-2028)
• 9.2 Latin America Hodgkin Lymphoma Treatment Market Size by Type
  • 9.2.1 Latin America Hodgkin Lymphoma Treatment Market Size by Type (2017-2022)
  • 9.2.2 Latin America Hodgkin Lymphoma Treatment Market Size by Type (2023-2028)
  • 9.2.3 Latin America Hodgkin Lymphoma Treatment Market Share by Type (2017-2028)
• 9.3 Latin America Hodgkin Lymphoma Treatment Market Size by Application
  • 9.3.1 Latin America Hodgkin Lymphoma Treatment Market Size by Application (2017-2022)
  • 9.3.2 Latin America Hodgkin Lymphoma Treatment Market Size by Application (2023-2028)
  • 9.3.3 Latin America Hodgkin Lymphoma Treatment Market Share by Application (2017-2028)
• 9.4 Latin America Hodgkin Lymphoma Treatment Market Size by Country
  • 9.4.1 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2017-2022)
  • 9.4.2 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size (2017-2028)
• 10.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type
  • 10.2.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application
  • 10.3.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country
  • 10.4.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Cell Medica Limited
  • 11.1.1 Cell Medica Limited Company Details
  • 11.1.2 Cell Medica Limited Business Overview
  • 11.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Introduction
  • 11.1.4 Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.1.5 Cell Medica Limited Recent Developments
• 11.2 Cellular Biomedicine Group, Inc.
  • 11.2.1 Cellular Biomedicine Group, Inc. Company Details
  • 11.2.2 Cellular Biomedicine Group, Inc. Business Overview
  • 11.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.2.4 Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.2.5 Cellular Biomedicine Group, Inc. Recent Developments
• 11.3 Constellation Pharmaceuticals, Inc.
  • 11.3.1 Constellation Pharmaceuticals, Inc. Company Details
  • 11.3.2 Constellation Pharmaceuticals, Inc. Business Overview
  • 11.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.3.4 Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.3.5 Constellation Pharmaceuticals, Inc. Recent Developments
• 11.4 Curis, Inc.
  • 11.4.1 Curis, Inc. Company Details
  • 11.4.2 Curis, Inc. Business Overview
  • 11.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.4.4 Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.4.5 Curis, Inc. Recent Developments
• 11.5 Faron Pharmaceuticals Oy
  • 11.5.1 Faron Pharmaceuticals Oy Company Details
  • 11.5.2 Faron Pharmaceuticals Oy Business Overview
  • 11.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Introduction
  • 11.5.4 Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.5.5 Faron Pharmaceuticals Oy Recent Developments
• 11.6 Fate Therapeutics, Inc.
  • 11.6.1 Fate Therapeutics, Inc. Company Details
  • 11.6.2 Fate Therapeutics, Inc. Business Overview
  • 11.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.6.4 Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.6.5 Fate Therapeutics, Inc. Recent Developments
• 11.7 Gamida Cell Ltd.
  • 11.7.1 Gamida Cell Ltd. Company Details
  • 11.7.2 Gamida Cell Ltd. Business Overview
  • 11.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Introduction
  • 11.7.4 Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.7.5 Gamida Cell Ltd. Recent Developments
• 11.8 Gilead Sciences, Inc.
  • 11.8.1 Gilead Sciences, Inc. Company Details
  • 11.8.2 Gilead Sciences, Inc. Business Overview
  • 11.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.8.4 Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.8.5 Gilead Sciences, Inc. Recent Developments
• 11.9 Incyte Corporation
  • 11.9.1 Incyte Corporation Company Details
  • 11.9.2 Incyte Corporation Business Overview
  • 11.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Introduction
  • 11.9.4 Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.9.5 Incyte Corporation Recent Developments
• 11.10 Merck & Co., Inc.
  • 11.10.1 Merck & Co., Inc. Company Details
  • 11.10.2 Merck & Co., Inc. Business Overview
  • 11.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.10.4 Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.10.5 Merck & Co., Inc. Recent Developments
• 11.11 Mirati Therapeutics Inc.
  • 11.11.1 Mirati Therapeutics Inc. Company Details
  • 11.11.2 Mirati Therapeutics Inc. Business Overview
  • 11.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.11.4 Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.11.5 Mirati Therapeutics Inc. Recent Developments
• 11.12 Molecular Templates Inc.
  • 11.12.1 Molecular Templates Inc. Company Details
  • 11.12.2 Molecular Templates Inc. Business Overview
  • 11.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.12.4 Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.12.5 Molecular Templates Inc. Recent Developments
• 11.13 NantKwest, Inc.
  • 11.13.1 NantKwest, Inc. Company Details
  • 11.13.2 NantKwest, Inc. Business Overview
  • 11.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Introduction
  • 11.13.4 NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022)
  • 11.13.5 NantKwest, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Alocrest
• Table 3. Key Players of ANK Program
• Table 4. Key Players of Azacitidine
• Table 5. Key Players of BMS-986016
• Table 6. Key Players of BPX-501
• Table 7. Key Players of Others
• Table 8. Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 9. Global Hodgkin Lymphoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 10. Global Hodgkin Lymphoma Treatment Market Size by Region (2017-2022) & (US$ Million)
• Table 11. Global Hodgkin Lymphoma Treatment Market Share by Region (2017-2022)
• Table 12. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 13. Global Hodgkin Lymphoma Treatment Market Share by Region (2023-2028)
• Table 14. Hodgkin Lymphoma Treatment Market Trends
• Table 15. Hodgkin Lymphoma Treatment Market Drivers
• Table 16. Hodgkin Lymphoma Treatment Market Challenges
• Table 17. Hodgkin Lymphoma Treatment Market Restraints
• Table 18. Global Hodgkin Lymphoma Treatment Revenue by Players (2017-2022) & (US$ Million)
• Table 19. Global Hodgkin Lymphoma Treatment Revenue Share by Players (2017-2022)
• Table 20. Global Top Hodgkin Lymphoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2021)
• Table 21. Ranking of Global Top Hodgkin Lymphoma Treatment Companies by Revenue (US$ Million) in 2021
• Table 22. Global 5 Largest Players Market Share by Hodgkin Lymphoma Treatment Revenue (CR5 and HHI) & (2017-2022)
• Table 23. Key Players Headquarters and Area Served
• Table 24. Key Players Hodgkin Lymphoma Treatment Product Solution and Service
• Table 25. Date of Enter into Hodgkin Lymphoma Treatment Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 28. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2017-2022)
• Table 29. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 30. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2023-2028)
• Table 31. Global Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 32. Global Hodgkin Lymphoma Treatment Revenue Share by Application (2017-2022)
• Table 33. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 34. Global Hodgkin Lymphoma Treatment Revenue Share by Application (2023-2028)
• Table 35. North America Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 36. North America Hodgkin Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million)
• Table 37. North America Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 38. North America Hodgkin Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million)
• Table 39. North America Hodgkin Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million)
• Table 40. North America Hodgkin Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million)
• Table 41. Europe Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 42. Europe Hodgkin Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million)
• Table 43. Europe Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 44. Europe Hodgkin Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million)
• Table 45. Europe Hodgkin Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million)
• Table 46. Europe Hodgkin Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million)
• Table 51. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Region (2017-2022) & (US$ Million)
• Table 52. Asia Pacific Hodgkin Lymphoma Treatment Market Size by Region (2023-2028) & (US$ Million)
• Table 53. Latin America Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 54. Latin America Hodgkin Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million)
• Table 55. Latin America Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 56. Latin America Hodgkin Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million)
• Table 57. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million)
• Table 58. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Type (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Type (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Application (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Application (2023-2028) & (US$ Million)
• Table 63. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Country (2017-2022) & (US$ Million)
• Table 64. Middle East and Africa Hodgkin Lymphoma Treatment Market Size by Country (2023-2028) & (US$ Million)
• Table 65. Cell Medica Limited Company Details
• Table 66. Cell Medica Limited Business Overview
• Table 67. Cell Medica Limited Hodgkin Lymphoma Treatment Product
• Table 68. Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 69. Cell Medica Limited Recent Developments
• Table 70. Cellular Biomedicine Group, Inc. Company Details
• Table 71. Cellular Biomedicine Group, Inc. Business Overview
• Table 72. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Product
• Table 73. Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 74. Cellular Biomedicine Group, Inc. Recent Developments
• Table 75. Constellation Pharmaceuticals, Inc. Company Details
• Table 76. Constellation Pharmaceuticals, Inc. Business Overview
• Table 77. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Product
• Table 78. Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 79. Constellation Pharmaceuticals, Inc. Recent Developments
• Table 80. Curis, Inc. Company Details
• Table 81. Curis, Inc. Business Overview
• Table 82. Curis, Inc. Hodgkin Lymphoma Treatment Product
• Table 83. Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 84. Curis, Inc. Recent Developments
• Table 85. Faron Pharmaceuticals Oy Company Details
• Table 86. Faron Pharmaceuticals Oy Business Overview
• Table 87. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product
• Table 88. Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 89. Faron Pharmaceuticals Oy Recent Developments
• Table 90. Fate Therapeutics, Inc. Company Details
• Table 91. Fate Therapeutics, Inc. Business Overview
• Table 92. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Product
• Table 93. Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 94. Fate Therapeutics, Inc. Recent Developments
• Table 95. Gamida Cell Ltd. Company Details
• Table 96. Gamida Cell Ltd. Business Overview
• Table 97. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Product
• Table 98. Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 99. Gamida Cell Ltd. Recent Developments
• Table 100. Gilead Sciences, Inc. Company Details
• Table 101. Gilead Sciences, Inc. Business Overview
• Table 102. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Product
• Table 103. Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 104. Gilead Sciences, Inc. Recent Developments
• Table 105. Incyte Corporation Company Details
• Table 106. Incyte Corporation Business Overview
• Table 107. Incyte Corporation Hodgkin Lymphoma Treatment Product
• Table 108. Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 109. Incyte Corporation Recent Developments
• Table 110. Merck & Co., Inc. Company Details
• Table 111. Merck & Co., Inc. Business Overview
• Table 112. Merck & Co., Inc. Hodgkin Lymphoma Treatment Product
• Table 113. Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 114. Merck & Co., Inc. Recent Developments
• Table 115. Mirati Therapeutics Inc. Company Details
• Table 116. Mirati Therapeutics Inc. Business Overview
• Table 117. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Product
• Table 118. Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 119. Mirati Therapeutics Inc. Recent Developments
• Table 120. Molecular Templates Inc. Company Details
• Table 121. Molecular Templates Inc. Business Overview
• Table 122. Molecular Templates Inc. Hodgkin Lymphoma Treatment Product
• Table 123. Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 124. Molecular Templates Inc. Recent Developments
• Table 125. NantKwest, Inc. Company Details
• Table 126. NantKwest, Inc. Business Overview
• Table 127. NantKwest, Inc. Hodgkin Lymphoma Treatment Product
• Table 128. NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2017-2022) & (US$ Million)
• Table 129. NantKwest, Inc. Recent Developments
• Table 130. Research Programs/Design for This Report
• Table 131. Key Data Information from Secondary Sources
• Table 132. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Hodgkin Lymphoma Treatment Market Share by Type: 2021 VS 2028
• Figure 2. Alocrest Features
• Figure 3. ANK Program Features
• Figure 4. Azacitidine Features
• Figure 5. BMS-986016 Features
• Figure 6. BPX-501 Features
• Figure 7. Others Features
• Figure 8. Global Hodgkin Lymphoma Treatment Market Share by Application: 2021 VS 2028
• Figure 9. Hospital Case Studies
• Figure 10. Clinic Case Studies
• Figure 11. Research Center Case Studies
• Figure 12. Hodgkin Lymphoma Treatment Report Years Considered
• Figure 13. Global Hodgkin Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 14. Global Hodgkin Lymphoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 15. Global Hodgkin Lymphoma Treatment Market Share by Region: 2021 VS 2028
• Figure 16. Global Hodgkin Lymphoma Treatment Market Share by Players in 2021
• Figure 17. Global Top Hodgkin Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2021)
• Figure 18. The Top 10 and 5 Players Market Share by Hodgkin Lymphoma Treatment Revenue in 2021
• Figure 19. North America Hodgkin Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million)
• Figure 20. North America Hodgkin Lymphoma Treatment Market Size Market Share by Type (2017-2028)
• Figure 21. North America Hodgkin Lymphoma Treatment Market Size Market Share by Application (2017-2028)
• Figure 22. North America Hodgkin Lymphoma Treatment Market Size Share by Country (2017-2028)
• Figure 23. United States Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Canada Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 25. Europe Hodgkin Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million)
• Figure 26. Europe Hodgkin Lymphoma Treatment Market Size Market Share by Type (2017-2028)
• Figure 27. Europe Hodgkin Lymphoma Treatment Market Size Market Share by Application (2017-2028)
• Figure 28. Europe Hodgkin Lymphoma Treatment Market Size Share by Country (2017-2028)
• Figure 29. Germany Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. France Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. U.K. Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Italy Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Russia Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Nordic Countries Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Asia-Pacific Hodgkin Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million)
• Figure 36. Asia Pacific Hodgkin Lymphoma Treatment Market Size Market Share by Type (2017-2028)
• Figure 37. Asia Pacific Hodgkin Lymphoma Treatment Market Size Market Share by Application (2017-2028)
• Figure 38. Asia Pacific Hodgkin Lymphoma Treatment Market Size Share by Region (2017-2028)
• Figure 39. China Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Japan Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. South Korea Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Southeast Asia Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. India Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. Australia Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 45. Latin America Hodgkin Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million)
• Figure 46. Latin America Hodgkin Lymphoma Treatment Market Size Market Share by Type (2017-2028)
• Figure 47. Latin America Hodgkin Lymphoma Treatment Market Size Market Share by Application (2017-2028)
• Figure 48. Latin America Hodgkin Lymphoma Treatment Market Size Share by Country (2017-2028)
• Figure 49. Mexico Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Brazil Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 51. Middle East & Africa Hodgkin Lymphoma Treatment Market Size YoY (2017-2028) & (US$ Million)
• Figure 52. Middle East and Africa Hodgkin Lymphoma Treatment Market Size Market Share by Type (2017-2028)
• Figure 53. Middle East and Africa Hodgkin Lymphoma Treatment Market Size Market Share by Application (2017-2028)
• Figure 54. Middle East and Africa Hodgkin Lymphoma Treatment Market Size Share by Country (2017-2028)
• Figure 55. Turkey Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. Saudi Arabia Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. UAE Hodgkin Lymphoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 58. Cell Medica Limited Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 59. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 60. Constellation Pharmaceuticals, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 61. Curis, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 62. Faron Pharmaceuticals Oy Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 63. Fate Therapeutics, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 64. Gamida Cell Ltd. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 65. Gilead Sciences, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 66. Incyte Corporation Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 67. Merck & Co., Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 68. Mirati Therapeutics Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 69. Molecular Templates Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 70. NantKwest, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2017-2022)
• Figure 71. Bottom-up and Top-down Approaches for This Report
• Figure 72. Data Triangulation
• Figure 73. Key Executives Interviewed